These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34774720)

  • 1. Heavy Burden of Toxic Dilated Cardiomyopathy Among Young Adults: A Retrospective Study and Review of the Literature.
    Cinq-Mars A; Massot M; Belzile D; Turgeon PY; Dubois-Sénéchal SM; Laliberté C; Komlosy MÈ; Leblanc MH; Bergeron S; O'Connor K; Morin J; Bourgault C; Bernier M; Beaudoin J; Radermaker S; Laflamme M; Charbonneau E; Sénéchal M
    Can J Cardiol; 2022 Jan; 38(1):49-58. PubMed ID: 34774720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilated cardiomyopathy with re-worsening left ventricular ejection fraction.
    Nabeta T; Inomata T; Ishii S; Yazaki M; Fujita T; Iida Y; Ikeda Y; Maekawa E; Naruke T; Koitabashi T; Ako J
    Heart Vessels; 2019 Jan; 34(1):95-103. PubMed ID: 29942977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy.
    Enzan N; Matsushima S; Ide T; Kaku H; Tohyama T; Funakoshi K; Higo T; Tsutsui H
    J Am Heart Assoc; 2021 Jun; 10(12):e019240. PubMed ID: 34053244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Left Ventricular Assist Device in the Recovery of Severe Amphetamine-Associated Dilated Cardiomyopathy.
    Soucy-Giguère MC; Cinq-Mars A; Charbonneau É; Voisine P; Beaudoin J; Dubois M; Sénéchal M
    Can J Cardiol; 2020 Feb; 36(2):317.e5-317.e7. PubMed ID: 31932114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure.
    Mancini DM; Beniaminovitz A; Levin H; Catanese K; Flannery M; DiTullio M; Savin S; Cordisco ME; Rose E; Oz M
    Circulation; 1998 Dec; 98(22):2383-9. PubMed ID: 9832482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of non-ischemic dilated cardiomyopathy patients with left ventricular ejection fraction ≤19% on medical therapy.
    Agstam S; Bahl A; Kumar RM
    Indian Heart J; 2020; 72(6):557-562. PubMed ID: 33357645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices.
    Dandel M; Weng Y; Siniawski H; Potapov E; Lehmkuhl HB; Hetzer R
    Circulation; 2005 Aug; 112(9 Suppl):I37-45. PubMed ID: 16159848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy.
    Persoon S; Paulus M; Hirt S; Jungbauer C; Dietl A; Luchner A; Schmid C; Maier LS; Birner C
    Heart Vessels; 2018 Aug; 33(8):948-957. PubMed ID: 29546540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery.
    Imamura T; Kinugawa K; Hatano M; Fujino T; Muraoka H; Inaba T; Maki H; Kagami Y; Endo M; Kinoshita O; Nawata K; Kyo S; Ono M
    J Artif Organs; 2014 Mar; 17(1):23-32. PubMed ID: 24337665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful bridge to resynchronization therapy with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy.
    Nishimura M; Ogiwara M; Ishikawa M; Imanaka K; Okamura N; Kato M; Asano H; Katogi T; Kohmoto O; Matsumoto K; Nishimura S; Kyo S
    J Artif Organs; 2005; 8(3):210-3. PubMed ID: 16235039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Chimura M; Onishi T; Tsukishiro Y; Sawada T; Kiuchi K; Shimane A; Okajima K; Yamada S; Taniguchi Y; Yasaka Y; Kawai H
    Heart; 2017 May; 103(9):679-686. PubMed ID: 27799316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results.
    Birks EJ; Drakos SG; Patel SR; Lowes BD; Selzman CH; Starling RC; Trivedi J; Slaughter MS; Alturi P; Goldstein D; Maybaum S; Um JY; Margulies KB; Stehlik J; Cunningham C; Farrar DJ; Rame JE
    Circulation; 2020 Nov; 142(21):2016-2028. PubMed ID: 33100036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial regenerative therapy using a scaffold-free skeletal-muscle-derived cell sheet in patients with dilated cardiomyopathy even under a left ventricular assist device: a safety and feasibility study.
    Yoshikawa Y; Miyagawa S; Toda K; Saito A; Sakata Y; Sawa Y
    Surg Today; 2018 Feb; 48(2):200-210. PubMed ID: 28821963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy.
    Mathier MA; Rose GA; Fifer MA; Miyamoto MI; Dinsmore RE; Castaño HH; Dec GW; Palacios IF; Semigran MJ
    J Am Coll Cardiol; 1998 Jul; 32(1):216-24. PubMed ID: 9669273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy.
    Ito E; Miyagawa S; Fukushima S; Yoshikawa Y; Saito S; Saito T; Harada A; Takeda M; Kashiyama N; Nakamura Y; Shiozaki M; Toda K; Sawa Y
    Ann Thorac Surg; 2017 Nov; 104(5):1531-1539. PubMed ID: 28760462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience.
    Fornaro A; Olivotto I; Rigacci L; Ciaccheri M; Tomberli B; Ferrantini C; Coppini R; Girolami F; Mazzarotto F; Chiostri M; Milli M; Marchionni N; Castelli G
    Eur J Heart Fail; 2018 May; 20(5):898-906. PubMed ID: 29148208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy.
    Weinmann K; Werner J; Koenig W; Rottbauer W; Walcher D; Keßler M
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31731547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Temporary mechanical left heart support. Recovery of heart function in patients with end-stage idiopathic dilated cardiomyopathy].
    Müller J; Wallukat G; Weng YG; Dandel M; Spiegelsberger S; Semrau S; Brandes K; Bieda H; Hummel M; Loebe M; Meyer R; Hetzer R
    Herz; 1997 Oct; 22(5):227-36. PubMed ID: 9441154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.